Home
NICE Guidance

Guidance list

Published
In consultation
In development
Proposed
About NICE guidance

Select status: Published In consultation In development Proposed

Filter by title

Sort by: Title (A - Z) Title (Z - A) Consultation (A - Z) Consultation (Z - A) Type (A - Z) Type (Z - A) Consultation end date (Newest) Consultation end date (Oldest)

Filter by consultation end date

Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and September 2020

From

Filter by type

Guidance

NICE guidelines

Antimicrobial prescribing guidelines Cancer service guidelines Clinical guidelines COVID-19 rapid guidelines Medicines practice guidelines Public health guidelines Safe staffing guidelines Social care guidelines

Diagnostics guidance Highly specialised technologies guidance Interventional procedures guidance Medical technologies guidance Quality standards Technology appraisal guidance

NICE advice

Evidence summaries

Antimicrobial prescribing evidence summaries COVID-19 rapid evidence summaries

Key therapeutic topics Local government briefings Medtech innovation briefings

Showing 1 to 1 of 1

In consultation NICE guidance
Title	Consultation	Type	Consultation end date	Sort date
Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma [ID1477]	Appraisal consultation: 1	Technology appraisal guidance	Type:25 June 2020	20200625